Investor Relations
Financial calendar
- 14/11/24
Interim report, Q3 2024
- 06/02/25
Year-end report, Q4 2024
- 01/05/25
2024 Annual Report
Latest press releases
Notice to attend the Extraordinary General Meeting in ExpreS2ion Biotech Holding AB (publ)
N.B. This notice has been prepared in both Swedish and English language versions. In the event of any discrepancies between the versions, the Swedish version shall prevail. The shareholders of ExpreS2ion Biotech Holding AB (publ), reg. no. 559033-3729 (the "Company"), are hereby given notice to attend the Extraordinary General Meeting to be held on 21…
Read moreExpreS2ion to present in upcoming investor events
Hørsholm, Denmark, 10 September 2024 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") will participate in upcoming investor events, including Investing in Life Science: From Seed to Success and a Danish Stock seminar for institutional investors.
Read moreExpreS2ion announces publication of sponsored research reports
Hørsholm, Denmark, 23 August 2024 – ExpreS2ion Biotech Holding AB (Nasdaq First North Growth Market: EXPRS2) is pleased to announce the publication of two new research reports by sponsored analysts, which delve into the fundamentals of the company’s innovative pipeline and proprietary ExpreS2 platform.
Read moreLatest presentations
BioStock Life Science
- From Seed To Success
16 September 2024
Presentation of
half-year results
15 August 2024
2024
Rights Issue Webinar
14 June 2024